Masoprocol - GlaxoSmithKline
Alternative Names: Actinex; CHX 100; meso-NDGA; SP 134101Latest Information Update: 24 Oct 2021
At a glance
- Originator Access Pharmaceuticals
- Developer Abeona Therapeutics; Access Pharmaceuticals; GlaxoSmithKline; GSK
- Class Anti-inflammatories; Catechols; Lignans; Small molecules
- Mechanism of Action Lipoxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Actinic keratosis
- Discontinued Cancer; Photodamage
Most Recent Events
- 05 Dec 2001 Discontinued-Clinical for Photodamage in USA (Topical)
- 05 Dec 2001 Discontinued-Preclinical for Cancer in USA (PO)
- 05 Dec 2001 No-Development-Reported for Actinic keratosis in Australia (Topical)